Acyclovir (ACV) has been investigated during the past years, mainly due to its antiviral activity. Assessment of possible incompatibility between an active component and different excipients along with the evaluation of thermal stability are crucial parts of a normal study prior to the final formulation setting of a medicine. Thermal analysis studies were used as important and complementary tools during pre-formulation to determine the compatibility of drug-excipients with the purpose of developing an acyclovir extended release formulation. Fourier transform infrared spectroscopy (FT-IR) and x-ray powder diffraction (XRPD) analyses were also realized. The results showed that ACV only exhibited interaction that could influence the stability of the product in the binary mixtures of ACV/magnesium stearate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
P. K. Gosh, R. J. Majithiya, M. L. Umerethia, et al., AAPS Pharm. Sci. Tech., 7, 1 – 6 (2006).
I. A. Attia, S. A. El-Gizawy, M. A Fouda, et al., AAPS Pharm. Sci. Tech., 8, 1 – 7 (2007).
S. C. Chen, Y. C. Wu, F. L. Mi, et al., J. Control. Rel., 96, 285 – 300 (2004).
S. J. Cheu, R. R. L Chen, P. F. Chen, et al., J. Microencapsul., 18, 559 – 565 (2001).
E. G. Jalón, M. J. Blanco-Príeto, P. Ygartua, et al., J. Control. Rel., 75, 191 – 197 (2001).
S. L. Law, K. J Huang, and C. H. Chiang, J. Control. Rel., 63, 135 – 140 (2000).
Z. P Pavelic, N. Skalko-Basnet, J. Filipovic-Grcic, et al., J. Control. Rel., 106, 34 – 43 (2005).
C. V. Rossel, J. S. Carrenõ, M. R. Baeza, et al., Quím. Nova, 23, 749 – 752 (2000).
C. M. Sancho, R. H. Vanrell, and S. Negro, J. Microencapsul., 20, 799 – 810 (2003).
H. K. Stulzer, L. Lacerda, M. P. Tagliari, et al., Carbohydr. Polym., 73, 490 – 497 (2008).
R. K. Verma, D. M. Krishna, and S. Garg, J. Control. Rel., 79, 7 – 27 (2002).
R. K. Verma and S. Garg, Pharm. Technol., 25, 1 – 14 (2001).
A. Bernardos, E. Aznar, C. Coll, et al., J. Control. Rel., 131, 181 – 189 (2008).
D. A. Fluri, C. Kemmer, M. Daoud-El Baba, et al., J. Control. Rel., 131, 211 – 219 (2008).
M. V. S Verma, A. M. Kaushal, A. Garg, et al., Am. J. Drug Deliv., 2, 43 – 57 (2004).
K. Jackson, D. Young, and S. Pant, Pharm. Sci. Technol. Today, 3, 336 (2000).
P. Mura, M. T. Faucci, A. Manderioli, et al., J. Pharm. Biomed. Anal., 18, 151 (1998).
P. C. Mora, M. Cirri, and P. Mura, J. Pharm. Biomed. Anal., 42, 3 – 10 (2006).
A. R. Fassihi and P. H. R. Persicaner, Int. J. Pharm., 37, 167 – 170 (1987).
P. Crowley and L. Martini, Pharm. Technol. Eur., 13, 26 – 34 (2001).
M. Tomassetti, A. Catalani, V. Rossi, et al., J. Pharm. Biomed. Anal., 37, 949 – 955 (2005).
M. N. Freitas, R. Alves, J. R. Matos, et al., J. Pharm. Biomed. Anal., 87, 905 – 911 (2007).
A. C. Moffatt, M. D. Osselton, and B. Widdop, Clarke’s Analysis of Drugs and Poisons, The Pharmaceutical Press, London (2004).
COE, European Pharmacopoeia, TSO (2007).
R. K. Verma and S. Garg, J. Pharm. Biomed. Anal., 38, 633 (2005).
L. C. S. Cides, A. A. S. Araújo, M. Santos-Filho, et al., J. Therm. Anal. Calorim., 84, 441 – 445 (2006).
G. G. G. Oliveira, H. F. G. Ferraz, and J. R. S. Matos, J. Therm. Anal. Calorim., 79, 267 (2005).
G. Pyramides, J. W. Robinson, and S. W. Zito, J. Pharm. Biomed. Anal., 13, 103 (1995).
H. K. Stulzer, P. O. Rodrigues, and T. M. Cardoso, J. Therm. Anal. Calorim., 91, 323 – 328 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barboza, F., Vecchia, D.D., Tagliari, M.P. et al. Differential scanning calorimetry as a screening technique in compatibility studies of acyclovir extended release formulations. Pharm Chem J 43, 363–368 (2009). https://doi.org/10.1007/s11094-009-0304-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-009-0304-1